Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19

SIMPLE SUMMARY: Individuals with chronic myeloid leukemia (CML) are different from other individuals with oncohematological disease (OHD) because they receive treatment with drugs that may modulate the activity of cells from the immune system, causing an increase in their activity against the cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Mora, Sara, Corona, Magdalena, Solera Sainero, Miriam, Mateos, Elena, Torres, Montserrat, Sánchez-Menéndez, Clara, Casado-Fernández, Guiomar, García-Pérez, Javier, Pérez-Olmeda, Mayte, Murciano-Antón, María Aranzazu, López-Jiménez, Javier, Coiras, Mayte, García-Gutiérrez, Valentín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604981/
https://www.ncbi.nlm.nih.gov/pubmed/37894433
http://dx.doi.org/10.3390/cancers15205066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604981/
https://www.ncbi.nlm.nih.gov/pubmed/37894433
http://dx.doi.org/10.3390/cancers15205066

Ejemplares similares